Guided Therapeutics (GTHP) Assets Average (2012 - 2025)
Guided Therapeutics recorded quarterly Assets Average of $1.1 million in Q4 2025, up 20.84% quarter-over-quarter from $921500.0 in Q3 2025, and down 15.23% year-over-year from $1.3 million in Q4 2024.
Guided Therapeutics' Assets Average history runs 14 years deep, the most recent figure standing at $1.1 million for Q4 2025.
- In Q4 2025, Assets Average fell 15.23% year-over-year to $1.1 million; the TTM figure through Dec 2025 stood at $1.1 million (down 15.23% YoY), while the FY2025 annual figure was $1.4 million, down 11.32% from the prior year.
- Assets Average came in at $1.1 million for Q4 2025 at Guided Therapeutics, up from $921500.0 in the prior quarter.
- In the past five years, Assets Average ranged from a high of $3.6 million in Q4 2022 to a low of $921500.0 in Q3 2025.
- A 5-year average of $1.9 million and a median of $1.9 million in 2021 frame the typical range for Assets Average.
- Across the five-year window, Assets Average soared 239.13% in 2021 and tumbled 51.0% in 2023, its largest moves.
- Guided Therapeutics' Assets Average stood at $1.9 million in 2021, then jumped by 91.25% to $3.6 million in 2022, then sank by 51.0% to $1.8 million in 2023, then decreased by 25.92% to $1.3 million in 2024, then declined by 15.23% to $1.1 million in 2025.
- According to Business Quant data, Assets Average over the past three periods registered $1.1 million, $921500.0, and $953500.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.42 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.64 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.49 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.02 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.66 Bn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 1.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 921,500.00 |
| Jun 30, 2025 | 953,500.00 |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | 1.58 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 2.11 Mn |
| Jun 30, 2023 | 2.62 Mn |
| Mar 31, 2023 | 3.13 Mn |
| Dec 31, 2022 | 3.62 Mn |
| Sep 30, 2022 | 2.69 Mn |
| Jun 30, 2022 | 1.85 Mn |
| Mar 31, 2022 | 2.11 Mn |
| Dec 31, 2021 | 1.89 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 2.21 Mn |
| Mar 31, 2021 | 1.86 Mn |
| Dec 31, 2020 | 1.33 Mn |
| Sep 30, 2020 | 1.12 Mn |
| Jun 30, 2020 | 653,000.00 |
| Mar 31, 2020 | 772,000.00 |
| Dec 31, 2019 | 759,500.00 |
| Sep 30, 2019 | 299,500.00 |
| Jun 30, 2019 | 332,000.00 |
| Mar 31, 2019 | 320,000.00 |
| Dec 31, 2018 | 363,500.00 |
| Sep 30, 2018 | 454,500.00 |
| Jun 30, 2018 | 472,500.00 |
| Mar 31, 2018 | 466,500.00 |
| Dec 31, 2017 | 655,500.00 |
| Sep 30, 2017 | 1.21 Mn |
| Jun 30, 2017 | 1.50 Mn |
| Mar 31, 2017 | 1.49 Mn |
| Dec 31, 2016 | 1.78 Mn |
| Sep 30, 2016 | 2.19 Mn |
| Jun 30, 2016 | 2.34 Mn |
| Mar 31, 2016 | 2.44 Mn |
| Dec 31, 2015 | 2.64 Mn |
| Sep 30, 2015 | 3.40 Mn |
| Jun 30, 2015 | 3.30 Mn |
| Mar 31, 2015 | 2.80 Mn |
| Dec 31, 2014 | 3.38 Mn |
| Sep 30, 2014 | 3.77 Mn |
| Jun 30, 2014 | 3.21 Mn |
| Mar 31, 2014 | 2.96 Mn |
| Dec 31, 2013 | 3.12 Mn |
| Sep 30, 2013 | 3.66 Mn |
| Jun 30, 2013 | 3.99 Mn |
| Mar 31, 2013 | 3.53 Mn |
| Dec 31, 2012 | 4.12 Mn |
| Sep 30, 2012 | 4.14 Mn |
| Jun 30, 2012 | 3.30 Mn |
| Mar 31, 2012 | 3.70 Mn |